Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein (Monomer, MALS verified)

Artikelnummer: ABS-HLT-H82E7-25UG
Artikelname: Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein (Monomer, MALS verified)
Artikelnummer: ABS-HLT-H82E7-25UG
Hersteller Artikelnummer: HLT-H82E7-25ug
Alternativnummer: ABS-HLT-H82E7-25UG
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: Biotin
Hepatitis B is a potentially lifethreatening liver infection caused by the hepatitis B virus (HBV). The hepatitis B virus attacks the liver and can cause both acute and chronic diseases that put people at high risk of death from cirrhosis and liver cancer. The virus is most commonly transmitted from mother to child during birth and delivery, as well as through contact with blood or other body fluids. Hepatitis B virus (HBV) is a member of the hepadnaviral family. The virus particle (virion) consists of an outer lipid envelope and an icosahedral nucleocapsid core composed of the core protein. The nucleocapsid encloses the viral DNA and a DNA polymerase that has reverse transcriptase activity. The outer envelope contains embedded proteins that are involved in viral binding of, and entry into, susceptible cells. The surface antigens (HBsAg) decorating the lipid envelope of HBV are produced in excess during the life cycle of the virus, and its presence in blood indicates current hepatitis B infection. The Human HLAA*0201 HBV (FLLTKILTI) complex protein is a complex of HLAA*0201 of the MHC Class I, B2M, and FLLTKILTI peptide of the HBV. - Proteine/Peptide
Molekulargewicht: 36.3 kDa and 11.7 kDa
Tag: C-10*His & C-Avi
NCBI: 59606
Puffer: PBS, pH7.4
Reinheit: 90%
Formulierung: Liquid
Target-Kategorie: HLA-A*0201 & B2M & HBV (FLLTKILTI)
Immobilized Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein (Cat. No. HLT-H82E7) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.1-1 ng/mL (QC tested).
Immobilized Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein (Cat. No. HLT-H82E7) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Anti-B2M Antibody, Human IgG1 with a linear range of 0.1-1 ng/mL (Routinely tested).
Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.